The fate of the European Space Agency's Mars probe becomes more grim by the hour, but the mothership is in orbit and poised to examine the Red planet’s atmosphere for evidence of methane

Karolinksa spin out Dilaforette changes name to Modus Therapeutics and announces intention to conduct an Initial Public Offering

KU Leuven’s Centre for Drug Design and Discovery closes €60 million fund to turn academic research into new medicines

Ensuring that the EU institutions base their decisions on the best available (scientific) evidence is critical to protecting citizens, restoring public confidence in EU decision-making and to shaping a regulatory framework conducive to innovation and economic growth, writes Dirk Hudig, Secretary General of the European Risk Forum.

Karolinska Institutet’s first overseas branch – the Ming Wai Lau Centre for Reparative Medicine in Hong Kong – is due to open in October. The centre represents a solid reinforcement of KI’s research in the field and is expected to open doors for collaborations in Hong Kong and other parts of Asia – but the way there is paved with challenges

Mikael Östling has been nominated as the new Deputy President of KTH Royal Institute of Technology. Östling comes to the role from his current position as a researcher and head of department at Kista and brings considerable experience to the institute’s top management

Stiftelsen Promobilia, the Promobilia Foundation, has granted 6.6 million SEK over four years to Assist. Prof. Max Ortiz Catalan to support the establishment of the Biomechatronics and Neurorehabilitation Laboratory for translational research

New pact by major companies including Johnson & Johnson, Pfizer, Sanofi, AstraZeneca and Novartis follows vow by global leaders for greater effort against superbugs